10.1002/cbic.200800491
Sigrist, C. J., Bridge, A., and Le Mercier, P. (2020). A potential role for integrins in host cell entry by SARS-CoV-2. Antiviral Research, 177, 104759. doi: 10.1016/j.antiviral.2020.104759
Smith, M. and Smith, J. C. (2020). Repurposing therapeutics for covid-19: Supercomputer-based docking to the sars-cov-2 viral spike protein and viral spike protein-human ace2 interface. ChemRxiv, Preprint. doi:10.26434/chemrxiv.11871402.v4
Stebbing, J., Phelan, A., Griffin, I., Tucker, C., Oechsle, O., Smith, D., and Richardson, P. (2020). COVID-19: combining antiviral and anti-inflammatory treatments. The Lancet Infectious Diseases, 20, 400-402. doi: 10.1016/S1473-3099(20)30132-8
Stower, H. (2020). Lopinavir-itonavir in severe COVID-19. Nature Medicine, 1. doi:10.1056/NEJMoa2001282
Talluri, S. (2020). Virtual Screening Based Prediction of Potential Drugs for COVID-19.Preprints, 2020020418. doi: